← All diseases
Cancer
Bile duct cancer
Would you like to receive a message when there is new research on cholangiocarcinoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a one-sentence summary explaining what was studied appears above each publication — and you'll be notified as soon as new research on Cholangiocarcinoma is published. View what Premium costs.
Publications and studies (2068)
- Multi-oil fat emulsion improves postoperative nutritional status and reduces complications in patients with hilar cholangiocarcinoma. (2025/09/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Elevated Creatine Kinase as a Marker for Aggressive GI Malignancy. (2025/09/12) ♡
- Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. (2025/09/01) ♡
- GLIM Criteria as Prognostic Factor in Patients Undergoing Adjuvant S-1 Chemotherapy for Biliary Tract Cancer. (2025/09/01) ♡
- SALL4 Is Required for YAP1-Dependent Malignant and Regenerative Hepatocyte-to-Cholangiocyte Reprogramming. (2025/09/01) ♡
- Potential Survival Benefit of Adjuvant Chemotherapy in Stage IV Intrahepatic Cholangiocarcinoma: A Multicenter, Stage-Stratified Analysis. (2025/08/31) ♡
- Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience. (2025/08/29) ♡
- Prognostic value of nutritional risk assessment indices in patients with digestive system tumors. (2025/08/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pediatric inflammatory bowel disease and cancer. (2025/08/27) ♡
- SALL4 is required for YAP1-dependent malignant and regenerative hepatocyte reprogramming into cholangiocyte lineage. (2025/08/19) ♡
- NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts. (2025/08/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Identification and Successful Treatment of Intrahepatic Cholangiocarcinoma After Fontan Procedure. (2025/08/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group. (2025/08/01) ♡
- Folliculin depletion results in liver cell damage and cholangiocarcinoma through MiT/TFE activation. (2025/08/01) ♡
- Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors. (2025/08/01) ♡
- A Medical Anthropology Assessment of Community Liver Cancer Risks: Qualitative Comparisons of Communities with Different Risk Profiles in Thailand. (2025/08/01) ♡
- Immediate Reconstruction of Pancretaticogastrostomy Following Hepatopancreatoduodenectomy for Biliary Tract Cancer: A Single-Center Review of 33 Consecutive Patients. (2025/07/18) ♡
- Effects of Huaier extract and autophagy factors on cholangiocarcinoma. (2025/07/18) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Oriental Cholangiohepatitis: An Overlooked Contributor to Cholangiocarcinoma Risk. (2025/07/08) ♡
- Meat consumption and risk of hepatobiliary cancers in the National Institutes of Health-AARP Diet and Health Study. (2025/07/01) ♡
- USSGAN: Unsupervised Spectral and Spatial Attention-Based Generative Adversarial Network for Cholangiocarcinoma Detection. (2025/07/01) ♡
- Metabolomic analysis of bioactive compounds in dill (Anethum graveolens L.) extracts. (2025/06/10) ♡
- Significance of the modified global leadership initiative on malnutrition (GLIM) criteria malcondition for patients with biliary tract cancer. (2025/06/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Preoperative blood and CT-image nutritional indicators in short-term outcomes and machine learning survival framework of intrahepatic cholangiocarcinoma. (2025/06/01) ♡
- Fufang-Biejia-Ruangan tablet targeting both cancer-associated fibroblasts and tumor cells by HIPPO-PI3K/AKT cascades in intrahepatic cholangiocarcinoma treatment. (2025/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Geographic diversity of human liver cancers mirrors global social inequalities. (2025/05/16) ♡
- A molecular network analysis and in silico docking of beta-eudesmol, atractylodin and hinesol in patients with advance stage intrahepatic cholangiocarcinoma. (2025/05/10) ♡
- Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-naïve periampullary tumors. (2025/05/01) ♡
- Preoperative Computed Tomography Radiomics-Based Models for Predicting Microvascular Invasion of Intrahepatic Mass-Forming Cholangiocarcinoma. (2025/05/01) ♡
- Favorable impact of hepatitis C virus infection control on recurrence after surgical resection for intrahepatic cholangiocarcinoma. (2025/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Surveillance of primary sclerosing cholangitis - a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study. (2025/05/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of preoperative biliary drainage in patients with Hilar Cholangiocarcinoma: a systematic review and meta-analysis. (2025/05/01) ♡
- A case of intraoperative intraductal ultrasonography-guided tumor-free resection margin in hilar cholangiocarcinoma (with videos). (2025/05/01) ♡
- Prognostic impact of albumin-bilirubin score in predicting the long-term survival of distal cholangiocarcinoma after radical surgery. (2025/04/24) ♡
- Survival benefits of chemotherapy, radiotherapy, and chemoradiotherapy in patients with unresectable intrahepatic cholangiocarcinoma: a population-based study. (2025/04/20) ♡
- Survival Outcomes of Preoperative Serum Biomarkers in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma. (2025/04/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endoscopic treatment of unresectable perihilar cholangiocarcinoma: beyond biliary drainage. (2025/04/14) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ethanol Ablation for Intrahepatic Bile Duct Dilatation in an Elderly Patient: A Case Report. (2025/04/04) ♡
- Evaluation of the validity of pancreatoduodenectomy in older patients with distal cholangiocarcinoma in terms of recurrence. (2025/04/03) ♡
- Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinoma. (2025/04/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pathological complete response after chemotherapy in initially unresectable distal cholangiocarcinoma. (2025/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Circulating tumor cell dynamic detecting to optimize neoadjuvant chemotherapy combined with liver transplantation in perihilar cholangiocarcinoma. (2025/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Machine learning based prediction model for bile leak following hepatectomy for liver cancer. (2025/04/01) ♡
- Morphological heterogeneity of IgG4-related hepatobiliary disease: further expanding the spectrum. (2025/04/01) ♡
- Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis. (2025/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Circulating tumor DNA in management of primary liver malignancy: A review of the literature and future directions. (2025/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary percutaneous metal stenting above the ampulla in resectable perihilar cholangiocarcinoma. (2025/04/01) ♡
- Evaluation of the validity of pancreatoduodenectomy for octogenarian patients with biliary tract carcinoma from the perspective of recurrence. (2025/04/01) ♡
- A Novel Definition and Grading Diagnostic Criteria for Tumour-Type-Specific Comprehensive Cachexia Risk. (2025/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rare Presentation of Eosinophilic Cholangitis in a 32-Year-Old Man. (2025/03/13) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.